Public Profile

Schering NV

Schering NV, a prominent player in the pharmaceutical industry, is headquartered in Belgium (BE) and operates extensively across Europe and North America. Founded in the late 19th century, the company has a rich history marked by significant milestones in drug development and innovation. Specialising in prescription medicines, Schering NV focuses on areas such as oncology, immunology, and gynaecology, offering unique products that address unmet medical needs. Their commitment to research and development has positioned them as a leader in the biopharmaceutical sector, with notable achievements in advancing therapies that improve patient outcomes. With a strong market presence, Schering NV continues to drive progress in healthcare, leveraging cutting-edge technology and scientific expertise to deliver high-quality solutions that enhance the quality of life for patients worldwide.

DitchCarbon Score

How does Schering NV's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

62

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Schering NV's score of 62 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Schering NV's reported carbon emissions

Schering NV, headquartered in Belgium (BE), currently does not provide specific carbon emissions data or reduction targets. Without available figures, it is challenging to assess their carbon footprint or climate commitments in detail. However, the company may still be engaged in various sustainability initiatives typical of the pharmaceutical industry, focusing on reducing environmental impact and enhancing energy efficiency. As the industry increasingly prioritises climate action, Schering NV's future commitments and strategies will be crucial in addressing climate change and achieving sustainability goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Schering NV's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Schering NV is in BE, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Schering NV is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Chiesi Ltd.

GB
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers